BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17596758)

  • 21. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies.
    Nieh S; Chen SF; Chu TY; Lai HC; Lin YS; Fu E; Gau CH
    Gynecol Oncol; 2005 Apr; 97(1):35-40. PubMed ID: 15790434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
    Shain AF; Kwok S; Folkins AK; Kong CS
    Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential influence of p16 immunohistochemical staining on the diagnosis of squamous cell lesions in cervical biopsy specimens: observation from cytologic-histologic correlation.
    Yang J; Elliott A; Hoffa AL; Herring N; Houser PM
    Cancer Cytopathol; 2018 Dec; 126(12):1003-1010. PubMed ID: 30307707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the Immunohistochemical Markers p16 and Ki-67 and Their Usefulness in the Diagnosis of Cervical Intraepithelial Neoplasms.
    de Melo FL; Lancellotti CL; da Silva MA
    Rev Bras Ginecol Obstet; 2016 Feb; 38(2):82-7. PubMed ID: 26883858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix.
    Nieh S; Chen SF; Chu TY; Lai HC; Fu E
    Gynecol Oncol; 2003 Oct; 91(1):201-8. PubMed ID: 14529682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interobserver reproducibility in determining p16 overexpression in cervical lesions : use of a combined scoring method.
    Vinyuvat S; Karalak A; Suthipintawong C; Tungsinmunkong K; Kleebkaow P; Trivijitsilp P; Siriaunkgul S; Triratanachat S; Khunamornpong S; Chuangsuwanich T; Settakorn J
    Asian Pac J Cancer Prev; 2008; 9(4):653-7. PubMed ID: 19256755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
    Castle PE; Adcock R; Cuzick J; Wentzensen N; Torrez-Martinez NE; Torres SM; Stoler MH; Ronnett BM; Joste NE; Darragh TM; Gravitt PE; Schiffman M; Hunt WC; Kinney WK; Wheeler CM; ;
    Arch Pathol Lab Med; 2020 Jun; 144(6):725-734. PubMed ID: 31718233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p16 Immunohistochemistry Interpretation by Nonpathologists as an Accurate Method for Diagnosing Cervical Precancer and Cancer.
    Liao GD; Kang LN; Chen W; Zhang X; Liu XY; Zhao FH; Stoler MH; Mills A; Xi MR; Qiao YL; Castle PE
    J Low Genit Tract Dis; 2015 Jul; 19(3):207-11. PubMed ID: 25171105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens.
    Bibbo M; Klump WJ; DeCecco J; Kovatich AJ
    Acta Cytol; 2002; 46(1):25-9. PubMed ID: 11843554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia.
    Kong CS; Balzer BL; Troxell ML; Patterson BK; Longacre TA
    Am J Surg Pathol; 2007 Jan; 31(1):33-43. PubMed ID: 17197917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of deeper levels and ancillary studies (p16(Ink4a) and ProExC) in reducing the discordance rate of Papanicolaou findings of high-grade squamous intraepithelial lesion and follow-up cervical biopsies.
    David O; Cabay RJ; Pasha S; Dietrich R; Leach L; Guo M; Mehrotra S
    Cancer; 2009 Jun; 117(3):157-66. PubMed ID: 19521978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discrepancy in the interpretation of cervical histology by gynecologic pathologists.
    Parker MF; Zahn CM; Vogel KM; Olsen CH; Miyazawa K; O'Connor DM
    Obstet Gynecol; 2002 Aug; 100(2):277-80. PubMed ID: 12151150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Test Characteristics of Specific p16 Clones in the Detection of High-grade Squamous Intraepithelial Lesions (HSIL).
    Shain AF; Wilbur DC; Stoler MH; Quade BJ; Kong CS
    Int J Gynecol Pathol; 2018 Jan; 37(1):82-87. PubMed ID: 28863068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-tiered score for Ki-67 and p16
    van Zummeren M; Leeman A; Kremer WW; Bleeker MCG; Jenkins D; van de Sandt M; Heideman DAM; Steenbergen R; Snijders PJF; Quint WGV; Berkhof J; Meijer CJLM
    J Clin Pathol; 2018 Nov; 71(11):981-988. PubMed ID: 30012698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CERTAIN Study Results: Adjunctive p16 Immunohistochemistry Use in Cervical Biopsies According to LAST Criteria.
    Wright TC; Stoler MH; Ferenczy A; Ranger-Moore J; Fang Q; Kapadia M; Singh S; Ridder R
    Am J Surg Pathol; 2021 Oct; 45(10):1348-1356. PubMed ID: 34232603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis.
    Qiao X; Bhuiya TA; Spitzer M
    J Low Genit Tract Dis; 2005 Apr; 9(2):100-7. PubMed ID: 15870531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk stratification by p16 immunostaining of CIN1 biopsies: a retrospective study of patients from the quadrivalent HPV vaccine trials.
    Mills AM; Paquette C; Castle PE; Stoler MH
    Am J Surg Pathol; 2015 May; 39(5):611-7. PubMed ID: 25602791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: correlation with biopsy follow-up results.
    Meyer JL; Hanlon DW; Andersen BT; Rasmussen OF; Bisgaard K
    Cancer; 2007 Apr; 111(2):83-92. PubMed ID: 17334990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.
    Maniar KP; Sanchez B; Paintal A; Gursel DB; Nayar R
    Am J Surg Pathol; 2015 Dec; 39(12):1708-18. PubMed ID: 26371784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.